Naproxen is classified as a nonsteroidal anti-inflammatory dug (NSAID) and was initially approved for prescription use in 1976 and then for over-the-counter (OTC) use in 1994. It can effectively manage acute pain as well as pain related to rheumatic diseases, and has a well studied adverse effect profile. Given its overall tolerability and effectiveness, naproxen can be considered a first line treatment for a variety of clinical situations requiring analgesia. Naproxen is available in both immediate and delayed release formulations, in combination with sumatriptan to treat migraines, and in combination with esomeprazole to lower the risk of developing gastric ulcers. It is grouped under the following drug class(es): Cyclooxygenase‑1 (COX‑1) Inhibitors, Cyclooxygenase‑2 (COX‑2) Inhibitors and Non-Steroidal Anti-Inflammatory Drugs (NSAID). Its therapeutic use is listed as analgesics, anti-inflammatories, antipyretics, antirheumatic agents and osteoarthritis agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include (S)-Naproxen, Naprosyn, Naproxene and Aleve. Its PubChem CID is 156391.
Naproxen
| CAS No | 22204-53-1 |
|---|---|
| Molecular Formula | C14H14O3 |
| Molecular Weight | 230.26 g/mol |
| Synonyms | (2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Naproxen is classified as a nonsteroidal anti-inflammatory dug (NSAID) and was initially approved for prescription use in 1976 and then for over-the-counter (OTC) use in 1994.
The listed CAS number is 22204-53-1.
The listed molecular formula is C14H14O3.
The listed molecular weight is 230.26 g/mol.
(2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid.
The source lists (S)-Naproxen, Naprosyn, Naproxene and Aleve.